Gershoni R - Search Results

1

Duplication in CHIT1 gene and the risk for Aspergillus lung disease in CF patients.

Livnat G, Bar-Yoseph R, Mory A, Dagan E, Elias N, Gershoni R, Bentur L. Livnat G, et al. Among authors: gershoni r. Pediatr Pulmonol. 2014 Jan;49(1):21-7. doi: 10.1002/ppul.22749. Epub 2013 Jan 28. Pediatr Pulmonol. 2014. PMID: 23359515

2

Leukocyte Adhesion Deficiency III: Report of Two Siblings.

Aygun D, Nepesov S, Gershoni R, Camcıoglu Y. Aygun D, et al. Among authors: gershoni r. Pediatr Neonatol. 2017 Feb;58(1):99-100. doi: 10.1016/j.pedneo.2016.07.006. Epub 2016 Nov 22. Pediatr Neonatol. 2017. PMID: 28043831 Free article. No abstract available.

3

[GENOTYPE-PHENOTYPE CORRELATIONS BY SPECIFIC FOUNDER VARIANTS IN BRCA IN ISRAELI WOMEN].

Michaelson-Cohen R, Laitman Y, Kedar I, Baris-Feldman H, Reish O, Lieberman S, Bernstein-Molho R, Goldberg Y, Reznick Levi G, Gershoni R, Beller U, Levy-Lahad E, Catan R, Friedman E. Michaelson-Cohen R, et al. Among authors: gershoni r. Harefuah. 2023 Jun;162(6):370-375. Harefuah. 2023. PMID: 37394440 Hebrew.

4

Subfertility, use of fertility treatments and BRCA mutation status and the risk of ovarian cancer.

Lerner-Geva L, Chetrit A, Farhi A, Lubin F, Sadezki S; National Israel Ovarian Cancer Study Group. Lerner-Geva L, et al. Arch Gynecol Obstet. 2022 Jul;306(1):209-217. doi: 10.1007/s00404-021-06355-6. Epub 2022 Jan 18. Arch Gynecol Obstet. 2022. PMID: 35039881

5

The effect of hysterectomy on survival of patients with borderline ovarian tumors.

Menczer J, Chetrit A, Sadetzki S; National Israel Ovarian Cancer Group. Menczer J, et al. Gynecol Oncol. 2012 May;125(2):372-5. doi: 10.1016/j.ygyno.2012.02.017. Epub 2012 Feb 21. Gynecol Oncol. 2012. PMID: 22366596

6

Ovarian carcinoma apparently confined to the ovaries--the accuracy of surgical staging in Israel.

Menczer J, Chetrit A, Sadetzki S; National Israel Ovarian Cancer Group. Menczer J, et al. Eur J Gynaecol Oncol. 2009;30(4):375-8. Eur J Gynaecol Oncol. 2009. PMID: 19761125

7

The effect of symptom duration in epithelial ovarian cancer on prognostic factors.

Menczer J, Chetrit A, Sadetzki S; National Israel Ovarian Cancer Group. Menczer J, et al. Arch Gynecol Obstet. 2009 Jun;279(6):797-801. doi: 10.1007/s00404-008-0814-1. Epub 2008 Oct 21. Arch Gynecol Obstet. 2009. PMID: 18936947

8

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.

Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Gronwald J, et al. Among authors: gershoni r. Int J Cancer. 2006 May 1;118(9):2281-4. doi: 10.1002/ijc.21536. Int J Cancer. 2006. PMID: 16331614

9

Prenatal diagnosis of Down syndrome: ten year experience in the Israeli population.

Shohat M, Frimer H, Shohat-Levy V, Esmailzadeh H, Appelman Z, Ben-Neriah Z, Dar H, Orr-Urtreger A, Amiel A, Gershoni R, Manor E, Barkai G, Shalev S, Gelman-Kohen Z, Reish O, Lev D, Davidov B, Goldman B. Shohat M, et al. Among authors: gershoni r. Am J Med Genet A. 2003 Oct 15;122A(3):215-22. doi: 10.1002/ajmg.a.20246. Am J Med Genet A. 2003. PMID: 12966521

10

Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel.

Hirsh-Yechezkel G, Chetrit A, Lubin F, Friedman E, Peretz T, Gershoni R, Rizel S, Struewing JP, Modan B. Hirsh-Yechezkel G, et al. Among authors: gershoni r. Gynecol Oncol. 2003 Jun;89(3):494-8. doi: 10.1016/s0090-8258(03)00152-5. Gynecol Oncol. 2003. PMID: 12798717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters